Alotano may be available in the countries listed below.
Alotano (DCIT) is known as Halothane in the US.
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
Famohexal may be available in the countries listed below.
Famotidine is reported as an ingredient of Famohexal in the following countries:
International Drug Name Search
Abbott Dobutamine Hcl may be available in the countries listed below.
Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Abbott Dobutamine Hcl in the following countries:
International Drug Name Search
Koi Med Anti Pilz may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Proflavine is reported as an ingredient of Koi Med Anti Pilz in the following countries:
International Drug Name Search
Citicolina Jet may be available in the countries listed below.
Citicoline sodium salt (a derivative of Citicoline) is reported as an ingredient of Citicolina Jet in the following countries:
International Drug Name Search
Virex may be available in the countries listed below.
Aciclovir is reported as an ingredient of Virex in the following countries:
International Drug Name Search
Epotrex-NP may be available in the countries listed below.
Erythropoietin is reported as an ingredient of Epotrex-NP in the following countries:
International Drug Name Search
Braunol may be available in the countries listed below.
Povidone-Iodine is reported as an ingredient of Braunol in the following countries:
International Drug Name Search
Zolaxa may be available in the countries listed below.
Olanzapine is reported as an ingredient of Zolaxa in the following countries:
International Drug Name Search
Zilfic may be available in the countries listed below.
Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Zilfic in the following countries:
International Drug Name Search
Penfluridol Nhwa may be available in the countries listed below.
Penfluridol is reported as an ingredient of Penfluridol Nhwa in the following countries:
International Drug Name Search
HyperHAES may be available in the countries listed below.
Hetastarch is reported as an ingredient of HyperHAES in the following countries:
Pentamidine is reported as an ingredient of HyperHAES in the following countries:
Pentastarch is reported as an ingredient of HyperHAES in the following countries:
International Drug Name Search
Cyclobenzaprine Hydrochloride (USAN) is known as Cyclobenzaprine in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Docateno may be available in the countries listed below.
Atenolol is reported as an ingredient of Docateno in the following countries:
International Drug Name Search
Myser may be available in the countries listed below.
Difluprednate is reported as an ingredient of Myser in the following countries:
International Drug Name Search
Alfadoxin may be available in the countries listed below.
Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Alfadoxin in the following countries:
International Drug Name Search
Lentonitrat may be available in the countries listed below.
Pentaerithrityl Tetranitrate is reported as an ingredient of Lentonitrat in the following countries:
International Drug Name Search
Cadalol may be available in the countries listed below.
Carvedilol is reported as an ingredient of Cadalol in the following countries:
International Drug Name Search
Generic Name: naphazoline (Ophthalmic route)
naf-AZ-oh-leen
In the U.S.
Available Dosage Forms:
Therapeutic Class: Decongestant
Pharmacologic Class: Sympathomimetic
Chemical Class: Imidazoline
Naphazoline is used to relieve redness due to minor eye irritations, such as those caused by colds, dust, wind, smog, pollen, swimming, or wearing contact lenses.
Some of these preparations are available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Use by infants and children is not recommended, since they are especially sensitive to the effects of naphazoline.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of naphazoline in the elderly with use in other age groups.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain naphazoline. It may not be specific to Ocu-Zoline. Please read with care.
Do not use naphazoline ophthalmic solution if it becomes cloudy or changes color.
Naphazoline should not be used in infants and children . It may cause severe slowing down of the central nervous system (CNS), which may lead to unconsciousness. It may also cause a severe decrease in body temperature.
Use this medicine only as directed. Do not use more of it, do not use it more often, and do not use it for more than 72 hours, unless otherwise directed by your doctor. To do so may make your eye redness and irritation worse and may also increase the chance of side effects.
To use:
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
If eye pain or change in vision occurs or if redness or irritation of the eye continues, gets worse, or lasts for more than 72 hours, stop using the medicine and check with your doctor.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Dexamethason PCH may be available in the countries listed below.
Dexamethasone is reported as an ingredient of Dexamethason PCH in the following countries:
International Drug Name Search
Ciprivax may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Ciprivax in the following countries:
International Drug Name Search
Koligin may be available in the countries listed below.
Meprobamate is reported as an ingredient of Koligin in the following countries:
International Drug Name Search
Nitrocontin may be available in the countries listed below.
Nitroglycerin is reported as an ingredient of Nitrocontin in the following countries:
International Drug Name Search
